Tootsie Roll Industries (TR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net product sales declined 6% year-over-year in Q2 2024 to $148.8M and 6% in H1 2024 to $300.3M, reflecting consumer resistance to higher prices and adverse timing of seasonal sales.
Net earnings rose to $15.6M in Q2 2024 (up 6%) and $31.5M in H1 2024 (up 12%), with EPS up 10% to $0.22 in Q2 and 13% to $0.44 in H1.
Gross profit margin improved due to higher price realization and manufacturing efficiencies, despite higher ingredient and labor costs.
Management expects continued sales headwinds and margin pressure in the second half of 2024 due to market resistance and elevated cocoa costs.
Financial highlights
Q2 2024 net product sales: $148.8M (down from $158.8M in Q2 2023); H1 2024: $300.3M (down from $319.5M).
Q2 2024 net earnings: $15.6M; H1 2024: $31.5M (up from $28.1M in H1 2023).
Q2 2024 EPS: $0.22 (up from $0.20); H1 2024 EPS: $0.44 (up from $0.39).
Q2 2024 gross margin: $50.5M (33.5% of revenue); H1 2024 gross margin: $100.5M.
Favorable freight, investment income, leasing revenue, and FX contributed to higher net earnings.
Outlook and guidance
Cocoa and chocolate costs have risen significantly and are expected to pressure margins in H2 2024 and 2025.
Management remains cautious about passing higher input costs to customers and consumers.
Plant expansion is under evaluation, with projected investment of $70M–$80M over the next five years, mostly in the next three years.
Latest events from Tootsie Roll Industries
- Proxy covers director elections, auditor ratification, and executive pay, with strong governance.TR
Proxy filing27 Mar 2026 - 2025 earnings rose on higher sales and margin recovery, with input costs and tariffs easing ahead.TR
Q4 202512 Feb 2026 - Annual meeting to elect directors and ratify auditor, with board oversight and controlled voting.TR
Proxy Filing2 Dec 2025 - Q3 2025 saw higher sales, earnings, and margins, but input costs and tariffs remain risks.TR
Q3 20257 Nov 2025 - Q2 sales and earnings rose, but margin risks from cocoa costs and tariffs persist.TR
Q2 20258 Aug 2025 - Q3 sales fell nearly 10%, but margins and EPS improved; cocoa costs and pension risks persist.TR
Q3 202413 Jun 2025 - Earnings rose 14% despite lower sales, but margin pressure from cocoa costs is expected ahead.TR
Q1 20256 Jun 2025 - Adjusted for tax effects, profit grew despite sales declines and rising input costs.TR
Q4 20245 Jun 2025